Quest Diagnostics Inc (DGX) financials

Quest Diagnostics Inc (DGX) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Quest Diagnostics Inc reported revenue of $11.04B, up 11.8% year over year, net income of $992M, diluted EPS of $8.75 and free cash flow of $1.36B.

Revenue (fiscal 2025)

$11.04B

Revenue growth (fiscal 2025)

11.8%

Net income (fiscal 2025)

$992M

Diluted EPS (fiscal 2025)

$8.75

Free cash flow (fiscal 2025)

$1.36B

Quest Diagnostics Inc files with the U.S. Securities and Exchange Commission under CIK 0001022079, classified as Services-Medical Laboratories.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.